Missing the point? Half of clinical trials collecting RWD don’t collect patient feedback

Researchers from the University of Ottawa (Canada) have investigated the frequency of patient engagement in pragmatic trials, which assess the impact of treatments for common illnesses. The findings indicated that real-world data (RWD) from patients was not collected in half of trials. The full report has been published in PLOS Medicine. The purpose of pragmatic trials is to investigate the impact of treatments that can be prescribed to a wide and diverse patient population. These studies should collect RWD on how treatments can affect patients, including factors such as pain, quality of life, disease burden and more. It is also...